1311 related articles for article (PubMed ID: 24555561)
1. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
Seña AC; Bachmann LH; Hobbs MM
Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
[TBL] [Abstract][Full Text] [Related]
2. A case of metronidazole-resistant Trichomonas vaginalis in pregnancy.
Forbes GL; Drayton R; Forbes GD
Int J STD AIDS; 2016 Sep; 27(10):906-8. PubMed ID: 26384945
[TBL] [Abstract][Full Text] [Related]
3. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis.
Sobel JD; Nyirjesy P; Brown W
Clin Infect Dis; 2001 Oct; 33(8):1341-6. PubMed ID: 11565074
[TBL] [Abstract][Full Text] [Related]
4. Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case reports of three patients.
Hager WD
Sex Transm Dis; 2004 Jun; 31(6):343-5. PubMed ID: 15167642
[TBL] [Abstract][Full Text] [Related]
5. Trichomoniasis and its treatment.
Nanda N; Michel RG; Kurdgelashvili G; Wendel KA
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):125-35. PubMed ID: 16441214
[TBL] [Abstract][Full Text] [Related]
6. Utility of antimicrobial susceptibility testing in Trichomonas vaginalis-infected women with clinical treatment failure.
Bosserman EA; Helms DJ; Mosure DJ; Secor WE; Workowski KA
Sex Transm Dis; 2011 Oct; 38(10):983-7. PubMed ID: 21934577
[TBL] [Abstract][Full Text] [Related]
7. Management of metronidazole-resistant Trichomonas vaginalis--a new approach.
Mammen-Tobin A; Wilson JD
Int J STD AIDS; 2005 Jul; 16(7):488-90. PubMed ID: 16004628
[TBL] [Abstract][Full Text] [Related]
8. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.
Cudmore SL; Delgaty KL; Hayward-McClelland SF; Petrin DP; Garber GE
Clin Microbiol Rev; 2004 Oct; 17(4):783-93, table of contents. PubMed ID: 15489348
[TBL] [Abstract][Full Text] [Related]
9. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis.
Dunne RL; Dunn LA; Upcroft P; O'Donoghue PJ; Upcroft JA
Cell Res; 2003 Aug; 13(4):239-49. PubMed ID: 12974614
[TBL] [Abstract][Full Text] [Related]
10. Resistant trichomoniasis: successful treatment with combination therapy.
Nyirjesy P; Gilbert J; Mulcahy LJ
Sex Transm Dis; 2011 Oct; 38(10):962-3. PubMed ID: 21934573
[TBL] [Abstract][Full Text] [Related]
11. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis.
Wendel KA; Erbelding EJ; Gaydos CA; Rompalo AM
Clin Infect Dis; 2002 Sep; 35(5):576-80. PubMed ID: 12173132
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of two plant extracts against vaginal trichomoniasis.
El-Sherbini GT; El Gozamy BR; Abdel-Hady NM; Morsy TA
J Egypt Soc Parasitol; 2009 Apr; 39(1):47-58. PubMed ID: 19530609
[TBL] [Abstract][Full Text] [Related]
13. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
[TBL] [Abstract][Full Text] [Related]
14. Managing vaginal trichomoniasis resistant to high-dose metronidazole therapy.
Lewis DA; Habgood L; White R; Barker KF; Murphy SM
Int J STD AIDS; 1997 Dec; 8(12):780-4. PubMed ID: 9433954
[No Abstract] [Full Text] [Related]
15.
Mtshali A; Ngcapu S; Govender K; Sturm AW; Moodley P; Joubert BC
Microbiol Spectr; 2022 Aug; 10(4):e0091222. PubMed ID: 35863010
[TBL] [Abstract][Full Text] [Related]
16. Treatment of metronidazole-resistant Trichomonas vaginalis.
Goldman LM; Upcroft JA; Workowski K; Rapkin A
Sex Health; 2009 Dec; 6(4):345-7. PubMed ID: 19917205
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole.
Schwebke JR; Barrientes FJ
Antimicrob Agents Chemother; 2006 Dec; 50(12):4209-10. PubMed ID: 17000740
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.
Kissinger PJ; Gaydos CA; Seña AC; Scott McClelland R; Soper D; Secor WE; Legendre D; Workowski KA; Muzny CA
Clin Infect Dis; 2022 Apr; 74(Suppl_2):S152-S161. PubMed ID: 35416973
[TBL] [Abstract][Full Text] [Related]
19. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis.
Narcisi EM; Secor WE
Antimicrob Agents Chemother; 1996 May; 40(5):1121-5. PubMed ID: 8723451
[TBL] [Abstract][Full Text] [Related]
20. In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis.
Crowell AL; Sanders-Lewis KA; Secor WE
Antimicrob Agents Chemother; 2003 Apr; 47(4):1407-9. PubMed ID: 12654679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]